A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Human Genetics

• Publication date

  1997-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9150151PMCID PMC1712432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutation nomenclature: Nicknames, systematic names, and unique identifiers

  1996cited by this paper
• Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.

  1996cited by this paper
• A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.

  1996cited by this paper
• Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

  1996influential reference
• New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families.

  1996cited by this paper
• The Majority of 22 Dutch High-Risk Breast Cancer Families Are due to Either BRCA1 or BRCA2

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

  1996cited by this paper
• BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.

  1996cited by this paper
• Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene

  1996cited by this paper
• A common BRCA1 mutation in Norwegian breast and ovarian cancer families?

  1996cited by this paper
• The genetics of breast and ovarian cancer.

  1995cited by this paper
• Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.

  1995cited by this paper
• Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population

  1995cited by this paper
• Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Rapid detection of BRCA1 mutations by the protein truncation test

  1995cited by this paper
• A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

  1995cited by this paper
• Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer

  1995cited by this paper
• The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

  1995cited by this paper
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

  1995cited by this paper
• Frontometaphyseal dysplasia: neonatal radiographic diagnosis.

  1995cited by this paper
• BRCA1 mutations in Ashkenazi Jewish women.

  1995cited by this paper
• Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test.

  1994cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• High-density genetic map of the BRCA1 region of chromosome 17q12-q21.

  1993cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Mutation of human short tandem repeats.

  1993cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

  1986cited by this paper
• Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes

  1986cited by this paper
• Cáncer

  1939cited by this paper

• The TESTBREAST journey: Revisiting the importance of early detection by frequent screening of women at high risk of breast cancer

  2025cites this paper
• PREVALENCE OF BRCA1 AND BRCA2 MUTATIONS AMONG BREAST AND OVARIAN CANCER PATIENTS IN NORTHERN EMIRATES

  2022cites this paper
• Deregulated Expression of Candidate MicroRNAs and BRCA Mutations Frequency in Breast Cancer Patients

  2021cites this paper
• Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

  2021cites this paper
• BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients

  2020cites this paper
• Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer

  2019cites this paper
• Germline mutations in cancer-predisposition genes in patients with biliary tract cancer

  2019cites this paper
• Hereditary Risk for Cancer

  2019cites this paper
• Hereditary breast and ovarian cancer genetics: Genetic testing in Serbia

  2018cites this paper
• BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

  2018cites this paper
• BRCA1 Testing—Advances and Retreats

  2017cites this paper
• New EPCAM founder deletion in Polish population

  2017cites this paper
• Mutations in context: implications of BRCA testing in diverse populations

  2017cites this paper
• Postpartum Breast Cancer in Hispanic Women: Epigenetics and microRNAs

  2015cites this paper
• ResearchPresymptomatic breast cancer in Egypt : role of BRCA 1 and BRCA 2 tumor suppressor genes mutations detection

  2015cites this paper
• Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.

  2015cites this paper
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

  2014cites this paper
• Analysis of novel mutations in BRCA1 in Iranian families with breast cancer.

  2014cites this paper
• Establishing a Program for Individuals at High Risk for Breast Cancer

  2013cites this paper
• Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

  2013cites this paper
• Talking to relatives about genetic testing for BRCA1/2 and its risk implications: an on-going discussion

  2013cites this paper
• Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

  2012cites this paper
• Identification and Characterization of BRCA 1 and BRCA 2 Founder Mutations

  2012cites this paper
• Molecular characterization of some mutations in BRCA1 and BRCA2 genes of breast cancer patients

  2012cites this paper
• Zinc(II)-cyclen polyacrylamide gel electrophoresis for detection of mutations in short Ade/Thy-rich DNA fragments.

  2011cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Genetic/familial high-risk assessment: breast and ovarian.

  2010cites this paper
• Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection

  2010cites this paper
• Assessing women at high risk of breast cancer: a review of risk assessment models.

  2010cites this paper
• High-Resolution Melting Analysis for Screening of Turkish Germline Mutations in BRCA1 and BRCA2

  2010cites this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• High-Resolution Melting Analysis for Screening of Turkish Germline Mutations in BRCA 1 and BRCA 2

  2010cites this paper
• Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy

  2009cites this paper
• The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer

  2009cites this paper
• Hereditary breast and ovarian cancer syndrome.

  2009cites this paper
• Hereditary Ovarian Cancer: Biology, Response to Chemotherapy and Prognosis

  2009cites this paper
• Analysis of BRCA1 and BRCA2 mutations in southern Iranian Breast cancer patients.

  2009cites this paper
• Clinical factors and biomarkers in ovarian tumors development.

  2008cites this paper
• EMQN Best Practice Guidelines for Molecular Genetic Analysis in Hereditary Breast/Ovarian Cancer

  2008cites this paper
• Genome‐wide linkage scan in Dutch hereditary non‐BRCA1/2 breast cancer families identifies 9q21‐22 as a putative breast cancer susceptibility locus

  2008cites this paper
• Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

  2008cites this paper
• BRCA1 gene mutation in familial breast cancer

  2008cites this paper
• Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

  2008cites this paper
• BRCA1 (185delAG) Mutation among Egyptian Breast Cancer Female Patients

  2008cites this paper
• BRCA1 and BRCA2 germline mutation analysis in the Indonesian population

  2007cites this paper
• Assessing Breast Cancer Risk and BRCA1/2 Carrier Probability

  2007cites this paper
• Founder mutations in BRCA1 and BRCA2 genes.

  2007cites this paper
• 4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).

  2007cites this paper
• BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses

  2007cites this paper
• Bmc Medical Genetics Multiplex Snapshot for Detection of Brca1/2 Common Mutations in Spanish and Spanish Related Breast/ovarian Cancer Families

  2007cites this paper
• Characterisation of BRCA1 genomic rearrangements in South African breast and/or ovarian cancer families

  2007cites this paper
• Genetic Screening and Counseling for High-Risk Populations

  2006cites this paper
• Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

  2006cites this paper
• A gift or a yoke? Women’s and men’s responses to genetic risk information from BRCA1 and BRCA2 testing

  2006cites this paper
• Genetics and the Young Woman with Breast Cancer

  2006cites this paper
• Low Frequency of 185delAG Founder Mutation of BRCA1 Gene in Iranian Breast Cancer Patients

  2006cites this paper
• Novel Germline BRCA1 and BRCA2 Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their Relatives

  2006cites this paper
• Molecular analysis of early onset Indonesian breast cancer

  2006cites this paper
• The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations

  2006cites this paper
• Population Genetics of BRCA 1 and BRCA 2

  2006cites this paper
• A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting

  2006cites this paper
• BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families

  2006cites this paper
• High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area

  2005cites this paper
• Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force

  2005cites this paper
• Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

  2005cites this paper
• Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families

  2005cites this paper
• Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital‐based screening

  2005cites this paper
• Effects of filtration on glyceraldehyde-3-phosphate dehydrogenase mRNA in the plasma of trauma patients and healthy individuals.

  2004cites this paper
• Genetic alterations in hereditary breast cancer.

  2004cites this paper
• BRCA1 mutations in South African breast and/or ovarian cancer families: Evidence of a novel founder mutation in Afrikaner families

  2004cites this paper
• Molecular analysis of the eighteen most frequent mutations in the BRCA1 gene in 63 Chilean breast cancer families.

  2004cites this paper
• BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families

  2004cites this paper
• BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect

  2004cites this paper
• Multiplex single-nucleotide primer extension analysis to simultaneously detect eleven BRCA1 mutations in breast cancer families.

  2004cites this paper
• Awareness of Genetic Testing for Increased Cancer Risk in the Year 2000 National Health Interview Survey

  2004cites this paper
• Founder mutations among the Dutch

  2004cites this paper
• Highly penetrant hereditary cancer syndromes

  2004cites this paper
• A high proportion of founder BRCA1 mutations in Polish breast cancer families

  2004cites this paper
• Selection in the Ashkenazi Jewish Population Unlikely—Reply to Zlotogora and Bach

  2003cites this paper
• Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics

  2003cites this paper
• distributions—in terms of numbers, frequencies, ages, and geography—are consistent with genetic drift alone.

  2003cites this paper
• Mutations of the BRCA1 Gene in Hereditary Breast and Ovarian Cancer in the Czech Republic

  2003cites this paper
• Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients

  2003cites this paper
• BRCA1 and BRCA2 mutations in Scotland and Northern Ireland

  2003influential citation
• Gene screening and prevention of hereditary breast cancer: A clinical view

  2003cites this paper
• Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania–Kujawy region of Poland

  2003cites this paper
• NCCN Genetic/Familial High-Risk Assessment: Breast Panel Members Genetic/Familial High-Risk Assessment: Breast

  2002cites this paper
• Genetic Counselling and Testing for Hereditary Breast and Ovarian Cancer: The Gent(le) Approach

  2002cites this paper
• Familial Breast and Ovarian Cancer: Management

  2002cites this paper
• Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer.

  2002cites this paper
• Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G

  2002cites this paper
• Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

  2002cites this paper
• Risk factors for ovarian cancer and early-onset breast cancer in Mongolia.

  2002cites this paper
• Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer

  2002cites this paper
• The ABCA4 2588G>C Stargardt mutation: single origin and increasing frequency from South-West to North-East Europe

  2002cites this paper
• Detection of a Single Base Substitution in Single Cells by Melting Peak Analysis Using Dual-Color Hybridization Probes

  2002cites this paper
• Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing

  2002cites this paper
• Risk assessment & genetic testing.

  2002cites this paper